FI770115A7 - - Google Patents

Download PDF

Info

Publication number
FI770115A7
FI770115A7 FI770115A FI770115A FI770115A7 FI 770115 A7 FI770115 A7 FI 770115A7 FI 770115 A FI770115 A FI 770115A FI 770115 A FI770115 A FI 770115A FI 770115 A7 FI770115 A7 FI 770115A7
Authority
FI
Finland
Application number
FI770115A
Other languages
Finnish (fi)
Inventor
Mario Gosalvez
Original Assignee
Mario Gosalvez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Gosalvez filed Critical Mario Gosalvez
Publication of FI770115A7 publication Critical patent/FI770115A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI770115A 1976-01-16 1977-01-14 FI770115A7 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES444380A ES444380A1 (es) 1976-01-16 1976-01-16 Un procedimiento para preparar derivados metalicos antraci- clinicos.

Publications (1)

Publication Number Publication Date
FI770115A7 true FI770115A7 (cg-RX-API-DMAC7.html) 1977-07-17

Family

ID=8470743

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770115A FI770115A7 (cg-RX-API-DMAC7.html) 1976-01-16 1977-01-14

Country Status (29)

Country Link
US (1) US4138480A (cg-RX-API-DMAC7.html)
JP (1) JPS52111555A (cg-RX-API-DMAC7.html)
AR (1) AR218620A1 (cg-RX-API-DMAC7.html)
AT (1) AT349634B (cg-RX-API-DMAC7.html)
AU (1) AU513698B2 (cg-RX-API-DMAC7.html)
BE (1) BE850438A (cg-RX-API-DMAC7.html)
CA (1) CA1070680A (cg-RX-API-DMAC7.html)
CH (1) CH629219A5 (cg-RX-API-DMAC7.html)
DD (1) DD129452A5 (cg-RX-API-DMAC7.html)
DE (1) DE2701405C2 (cg-RX-API-DMAC7.html)
DK (1) DK11877A (cg-RX-API-DMAC7.html)
EG (1) EG12735A (cg-RX-API-DMAC7.html)
ES (1) ES444380A1 (cg-RX-API-DMAC7.html)
FI (1) FI770115A7 (cg-RX-API-DMAC7.html)
FR (1) FR2338285A1 (cg-RX-API-DMAC7.html)
GB (1) GB1568263A (cg-RX-API-DMAC7.html)
GR (1) GR70696B (cg-RX-API-DMAC7.html)
HU (1) HU177832B (cg-RX-API-DMAC7.html)
IE (1) IE44689B1 (cg-RX-API-DMAC7.html)
IL (1) IL51264A (cg-RX-API-DMAC7.html)
NL (1) NL7700379A (cg-RX-API-DMAC7.html)
NO (1) NO770122L (cg-RX-API-DMAC7.html)
NZ (1) NZ183084A (cg-RX-API-DMAC7.html)
PH (1) PH16582A (cg-RX-API-DMAC7.html)
PL (1) PL108660B1 (cg-RX-API-DMAC7.html)
PT (1) PT66067B (cg-RX-API-DMAC7.html)
SE (1) SE7700398L (cg-RX-API-DMAC7.html)
SU (1) SU886748A3 (cg-RX-API-DMAC7.html)
YU (1) YU5477A (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959798A (en) * 1958-03-24 1960-11-15 Champlin Oil & Refining Co Pipe line cleaner
US4337335A (en) * 1978-05-18 1982-06-29 Schering Corporation Transition metal salt complexes of polyamino organic compounds
IT1184161B (it) * 1985-03-14 1987-10-22 Franco Conti Derivati del chitosano costituiti da complessi di coordinazione con ioni ferrosi
JPS63310830A (ja) * 1987-06-10 1988-12-19 Meiji Seika Kaisha Ltd 抗レトロウイルス剤
GB9613182D0 (en) * 1996-06-24 1996-08-28 Nycomed Imaging As Method
NL1009226C2 (nl) * 1998-05-20 1999-11-24 Faculteit Geneeskunde Universi Toepassing van een nucleïnezuur-bindend chemotherapeutisch agens, een farmaceutisch preparaat en een geneesmiddelcombinatie.
US20060198882A1 (en) * 2003-03-21 2006-09-07 Yechezkel Barenholz Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
CA2587470A1 (en) * 2004-11-15 2006-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusale M Combination therapy associating preferably a ceramide with a cytotoxic drug
WO2008100591A2 (en) * 2007-02-14 2008-08-21 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
EP3327148B1 (en) 2010-06-18 2021-03-17 Myriad Genetics, Inc. Methods of predicting the status of brca1 and brca2 genes in a cancer cell
DK2609216T3 (en) 2010-08-24 2016-09-12 Dana Farber Cancer Inst Inc Methods to predict anti-cancer response
WO2012174378A2 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
WO2013096843A1 (en) 2011-12-21 2013-06-27 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
CA2864481C (en) 2012-02-23 2020-07-14 The Children's Hospital Corporation Methods for predicting anti-cancer response
CA2867434C (en) 2012-06-07 2021-10-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
AU2014248007B2 (en) 2013-04-05 2020-03-26 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
US11149316B2 (en) 2013-12-09 2021-10-19 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
ES2800673T3 (es) 2014-08-15 2021-01-04 Myriad Genetics Inc Métodos y materiales para evaluar una deficiencia de recombinación homóloga
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1469430A (en) * 1974-12-24 1977-04-06 Farmaceutici Italia Daunomycin derivatives

Also Published As

Publication number Publication date
IE44689L (en) 1977-07-16
DD129452A5 (de) 1978-01-18
IE44689B1 (en) 1982-02-24
ATA19677A (de) 1978-09-15
YU5477A (en) 1982-06-30
ES444380A1 (es) 1977-06-16
PL108660B1 (en) 1980-04-30
SU886748A3 (ru) 1981-11-30
PT66067A (en) 1977-02-01
CA1070680A (en) 1980-01-29
IL51264A (en) 1980-05-30
NO770122L (no) 1977-07-19
DE2701405C2 (de) 1986-02-27
AU513698B2 (en) 1980-12-18
HU177832B (en) 1981-12-28
AU2131977A (en) 1978-07-20
PT66067B (en) 1978-06-23
FR2338285B1 (cg-RX-API-DMAC7.html) 1980-03-14
GB1568263A (en) 1980-05-29
EG12735A (en) 1981-03-31
AR218620A1 (es) 1980-06-30
BE850438A (fr) 1977-05-16
GR70696B (cg-RX-API-DMAC7.html) 1982-12-30
IL51264A0 (en) 1977-03-31
US4138480A (en) 1979-02-06
PH16582A (en) 1983-11-22
PL195344A1 (pl) 1978-08-14
SE7700398L (sv) 1977-07-17
DK11877A (da) 1977-07-17
DE2701405A1 (de) 1977-07-21
JPS52111555A (en) 1977-09-19
NL7700379A (nl) 1977-07-19
NZ183084A (en) 1980-04-28
AT349634B (de) 1979-04-10
JPS6133039B2 (cg-RX-API-DMAC7.html) 1986-07-31
CH629219A5 (de) 1982-04-15
FR2338285A1 (fr) 1977-08-12

Similar Documents

Publication Publication Date Title
FR2338285B1 (cg-RX-API-DMAC7.html)
FR2352598B1 (cg-RX-API-DMAC7.html)
FR2367242B3 (cg-RX-API-DMAC7.html)
FR2359249B1 (cg-RX-API-DMAC7.html)
FR2338825B1 (cg-RX-API-DMAC7.html)
JPS5329282U (cg-RX-API-DMAC7.html)
JPS5425945B2 (cg-RX-API-DMAC7.html)
JPS611145B2 (cg-RX-API-DMAC7.html)
JPS5348207U (cg-RX-API-DMAC7.html)
JPS5361618U (cg-RX-API-DMAC7.html)
JPS5523559Y2 (cg-RX-API-DMAC7.html)
JPS52118256U (cg-RX-API-DMAC7.html)
JPS5327160U (cg-RX-API-DMAC7.html)
JPS5379359U (cg-RX-API-DMAC7.html)
JPS5390120U (cg-RX-API-DMAC7.html)
JPS52103279U (cg-RX-API-DMAC7.html)
JPS5327585U (cg-RX-API-DMAC7.html)
JPS52157980U (cg-RX-API-DMAC7.html)
DD126147A1 (cg-RX-API-DMAC7.html)
DD126129A1 (cg-RX-API-DMAC7.html)
CH600503A5 (cg-RX-API-DMAC7.html)
DD125558A1 (cg-RX-API-DMAC7.html)
CH601538A5 (cg-RX-API-DMAC7.html)
BG23497A1 (cg-RX-API-DMAC7.html)
CH601921A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GOSALVEZ, MARIO